Howton David T
Chief Operating Officer
Howton David T has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Howton David T is listed as Chief Operating Officer at Solid Biosciences Inc. Inside the rolling window, Howton David T reported no open-market purchases and 4 open-market sales totaling $434K in SLDB. The largest disclosed transaction in the window is a sale of 37,771 SLDB shares on Feb 2, 2026, worth $243K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$434K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Howton David T made?
Howton David T has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Howton David T trade?
Howton David T has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Howton David T's most recent SEC Form 4 filing?
Howton David T's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Howton David T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Howton David T is listed as Chief Operating Officer.
What is Howton David T's total buy and sell value in the current window?
Inside the rolling retention window, Howton David T bought $0 and sold $434K based on SEC Form 4 filings.
What was Howton David T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 37,771 SLDB shares on 2026-02-02, worth $243K, per SEC Form 4 filings.